GHB / GBL

Depending on the dosage, GHB / GBL has either an anxiolytic and euphoric or narcotic effect. High doses can lead to a sudden coma-like sleep. Dosing is often difficult, as just a few drops can make a huge difference. "Top-ups" and mixed consumption with centrally depressant substances such as sleeping pills, opioids and alcohol (!) should be urgently avoided. Frequent use can lead to psychological and physical dependence.

INFORMATION ON RISK REDUCTION

Depending on the dosage, GHB / GBL acts either as an entactogen (= feelings and emotions are intensified) or as a sleeping pill. Caution: Concentration and purity can vary greatly, making it difficult to estimate the dose!!!

The alcohol-like effect dominates in low doses. It then has an anxiolytic, slightly euphoric and socially opening effect. A restriction of motor control then occurs, similar to alcohol intoxication. In higher doses, it may also have a sexually stimulating effect or generally intensify existing drives and moods. In very high doses, GHB has a strong soporific effect. This can lead to a sudden narcotic sleep from which the person can hardly be woken up. The duration of action of GHB / GBL is usually 1.5 to 3 hours.

During the acute effects of GHB / GBL, coordination disorders, dizziness and impaired cognitive performance occur. Above all, the ability to concentrate and attention are limited or delayed. At higher doses, nausea and nausea may occur.

GHB/GBL overdoses (i.e. doses that lead to unwanted anaesthesia) are extremely dangerous due to the risk of respiratory depression and possible respiratory arrest. The risk of an overdose is greatly increased by the additional intake of centrally depressant drugs such as sleeping pills, opioids and alcohol (!). Even a small dose of GHB/GBL can lead to a coma-like sleep!

GHB is probably metabolised in the body to GABA (gamma-aminobutyric acid) and thus indirectly influences the dopamine balance. In the 1980s, GHB was used by athletes as a doping agent, as it increases the release of growth hormones and thus promotes muscle growth.

Regular use of GHB / GBL can lead to psychological and physical dependence. If GHB / GBL is taken several times a week, users feel the need to increase the dose after a while. With very frequent use (several single doses per day), a pronounced dependence develops. In this case, sudden cessation (cold turkey) can lead to anxiety, panic attacks, nausea, sweating, hand tremors and insomnia. Furthermore, delirium with severe hallucinations can occur, similar to alcohol withdrawal. GHB/GBL withdrawal should always be carried out under medical supervision, as serious complications can occur during withdrawal!

  • Psychological problems, restlessness or anxiety.
  • During pregnancy and breastfeeding.
  • High blood pressure, heart and circulatory problems.
  • Liver or kidney damage
  • Epilepsy
  • Never drive a vehicle on the road after consumption!

If you consume GHB/GBL despite the health and criminal law risks, you should observe the following rules in addition to general information on risk reduction:

GHB/GBL should never be consumed with alcohol and/or centrally depressant medication such as sleeping pills or tranquillisers (e.g. Valium) and Opiates as this greatly increases the risk of unpleasant side effects (comatose deep sleep, respiratory arrest, etc.)!

Avoid "topping up". Even a small increase in the dose can lead to undesirable side effects.

Lay more often Breaks in which you cool down, relax and consume enough non-alcoholic drinks. However, no more than ½ litre per hour.

Refrain from consumption if you Fear before taking it or you are not feeling well.

Don't forget to protect yourself and your partner during sex. protect and use condoms

4-Hydroxybutanoic acid, also known as gamma-hydroxybutyric acid, or GHB for short, is closely related to the human neurotransmitter GABA (gamma-aminobutyric acid) and is also an independent neurotransmitter in the human body. It is found in food (e.g. in meat) in trace amounts. GHB is used in medicine as an intravenous narcotic for caesarean section deliveries in obstetric anaesthesia and in all kinds of high-risk cases (e.g. patients with liver damage). In 2002, it was approved in the USA and the EU as a drug for the symptomatic treatment of narcolepsy (sleeping sickness). Since the end of the 1990s, the substance has been used as a supposed party drug (liquid ecstasy).

Despite the name "liquid ecstasy", GHB has no chemical relationship to ecstasy (MDMA) and its effects are more similar to alcohol. The name is primarily a sales argument. It is usually available on the black market as a liquid in small bottles.

Since the ban on GHB, GBL (gamma-butyrolactone) is often consumed as a substitute, which is directly metabolised to GHB in the body and therefore has almost the same effect.

GHB has been subject to the Narcotic Drugs Act since 2002. The acquisition, possession, import and export, transfer to and procurement for others (transfer and sale) are punishable by law. Consumers who violate the SMG must expect a mandatory visit to a public health officer (in Vienna: the outpatient centre of the Addiction and Drug Coordination). Health-related measures can then be ordered there. If you adhere to these requirements, there will be no court proceedings. You can find more information about the law here: Laws. Since 1 January 2012, GBL has been subject to the New Psychoactive Substances Act (NPSG). This means that trafficking for profit (i.e. selling it) is a criminal offence. If it is possession for personal use, no further penalties are provided for.

Status: July 2022